Purchases and Sales Made in Q2 2022 in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX) during Q2 2022. The information is specifically focused on institutions that hold shares of Celldex Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2022
Q2 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-521K- 49.41% |
$10.7M - $19.4M
|
533K
$11.9M
|
|
|
Aug 15, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-537K- 52.7% |
$11M - $20M
|
482K
$10.7M
|
|
|
Oct 27, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-537K- 52.7% |
$11M - $20M
|
482K
$10.7M
|
|
|
Aug 15, 2022
Q2 2022
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-603K- 48.21% |
$12.4M - $22.5M
|
647K
$14.4M
|
|
|
Aug 15, 2022
Q2 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-689K- 19.53% |
$14.1M - $25.7M
|
2.84M
$63.2M
|